Get started
Author

Heng B. See

Demonstration of Improvements to the Bioluminescence Resonance Energy Transfer (BRET) Technology for the Monitoring of G Protein–Coupled Receptors in Live Cells
2008 · Martina Kocan, Heng B. See, et al. · SLAS DISCOVERY · 97
PDF
i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4
2016 · Katherine Griffiths, Olan Dolezal, et al. · Journal of Biological Chemistry · 73
Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time
2017 · Carl W. White, Hannah K. Vanyai, et al. · Scientific Reports · 58
PDF
Mutations of Vasopressin Receptor 2 Including Novel L312S Have Differential Effects on Trafficking
2016 · Anatoly Tiulpakov, Carl W. White, et al. · Molecular Endocrinology · 57
PDF
Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease
2015 · Mohammed Akli Ayoub, Yuan Zhang, et al. · PLoS ONE · 52
PDF
Application of G Protein-Coupled Receptor-Heteromer Identification Technology to Monitor β -Arrestin Recruitment to G Protein-Coupled Receptor Heteromers
2010 · Heng B. See, Ruth M. Seeber, et al. · Assay and Drug Development Technologies · 52
Identification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 Heteromer
2012 · Sanam Mustafa, Heng B. See, et al. · Journal of Biological Chemistry · 51
PDF
The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer
2021 · Emily Golden, Rabab Rashwan, et al. · Nature Communications · 48
PDF
Agonist-Independent Interactions between β-Arrestins and Mutant Vasopressin Type II Receptors Associated with Nephrogenic Syndrome of Inappropriate Antidiuresis
2009 · Martina Kocan, Heng B. See, et al. · Molecular Endocrinology · 47
NanoBRET ligand binding at a GPCR under endogenous promotion facilitated by CRISPR/Cas9 genome editing
2018 · Carl W. White, Elizabeth K.M. Johnstone, et al. · Cellular Signalling · 43
Investigation of Receptor Heteromers Using NanoBRET Ligand Binding
2021 · Elizabeth K. M. Johnstone, Heng B. See, et al. · International Journal of Molecular Sciences · 22
PDF
Disease‐associated missense variants in ZBTB18 disrupt DNA binding and impair the development of neurons within the embryonic cerebral cortex
2019 · Isabel A. Hemming, Olivier Clément, et al. · Human Mutation · 20
PDF
Insights into the Interaction of LVV-Hemorphin-7 with Angiotensin II Type 1 Receptor
2020 · Amanat Ali, Elizabeth K. M. Johnstone, et al. · International Journal of Molecular Sciences · 19
PDF
Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor
2022 · Elizabeth K. M. Johnstone, Mohammed Akli Ayoub, et al. · Frontiers in Endocrinology · 14
PDF
Profiling Epidermal Growth Factor Receptor and Heregulin Receptor 3 Heteromerization Using Receptor Tyrosine Kinase Heteromer Investigation Technology
2013 · Mohammed Akli Ayoub, Heng B. See, et al. · PLoS ONE · 14
PDF
Complex interactions between the angiotensin II type 1 receptor, the epidermal growth factor receptor and TRIO-dependent signaling partners
2021 · Elizabeth K.M. Johnstone, Rekhati S. Abhayawardana, et al. · Biochemical Pharmacology · 6
Positive modulation of glucagon‐like peptide 1 (GLP‐1) receptor by endogenous haemorphins with implications in glucose metabolism and diabetes
2026 · Farheen Badrealam Khan, Rwdah Mohamed Alameri, et al. · British Journal of Pharmacology
Detection and characterisation of GPCR heteromers using NanoBRET ligand binding
2019 · Elizabeth K. M. Johnstone, Heng B. See, et al. · UWA Profiles and Research Repository (University of Western Australia)
Profiling of a Novel NSIAD-Causing Mutation of Vasopressin Receptor 2 and its Differential Effect on Receptor Trafficking Compared to Previously Identified Mutations
2015 · Anatoly Tiulpakov, Carl W. White, et al. · 54th Annual ESPE
Profiling Novel Pharmacology Resulting from G Protein-Coupled Receptor Heteromerization
2011 · Kevin Donald Pfleger, Sanam Mustafa, et al. · The Endocrine Society eBooks
Agonist-Independent Interactions between β-Arrestins and Mutant Vasopressin Type II Receptors Associated with Nephrogenic Syndrome of Inappropriate Antidiuresis
2009 · Martina Kocan, Heng B. See, et al. · The Journal of Clinical Endocrinology & Metabolism
Works count: 21
Citation count: 673
H-index: 14
I10-index: 15
Year
Topic
Type